Literature DB >> 15003943

Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout.

Ryan A Dombkowski1, Michael J Russell, Kenneth R Olson.   

Abstract

Hydrogen sulfide (H(2)S) is an endogenous vasodilator in mammals, but its presence and function in other vertebrates is unknown. We generated H(2)S from NaHS and examined the effects on isolated efferent branchial arteries from steelhead (stEBA) or rainbow (rtEBA) trout. H(2)S concentration was measured colorimetrically (CM) and with ion-selective electrodes (ISE) in rainbow trout plasma. NaHS produced a triphasic response consisting of a relaxation (phase 1), constriction (phase 2), and relaxation (phase 3) in both unstimulated vessels and in stEBA precontracted with carbachol (Carb). Phase 1 and phase 3 in stEBA were decreased and phase 2 increased in unstimulated vessels by K(+)(ATP) channel inhibition (glibenclamide), or a cocktail of inhibitors of cyclooxygenase, lipoxygenase, and cytochrome P-450 (indomethacin, esculetin, and clotrimazole). Inhibition of soluble guanylate cyclase with ODQ o NS-2028 inhibited phase 3 in stEBA, although NaHS decreased cGMP production by tEBA. stEBA phase 2 contractions were partially inhibited by the myosin light chain kinase inhibitor, ML-9, but unaffected by L-type calcium channel inhibition (methoxyverapamil), whereas contraction in tEBA was partially inhibited by nifedipine or removal of extracellular calcium. Phase 3 relaxations were more pronounced in stEBA precontracted with Carb and no epinephrine (NE) than those cont acted by KCl or K(2)SO(4). stEBA phase 2 and phase 3 responses were dose dependent (EC(50) = 1.1 +/- 1.2 x 10(-3) M and 6.7 +/- 0.9 x 10(-5) M, respectively; n = 7). NaHS was also vasoactive in steelhead bulbus arteriosus, celiac mesenteric arteries, and anterior cardinal veins. Rainbow trout plasma sulfide concentration was 4.0 +/- 0.3 x 10(-5) M, n = 4 (CM) and 3.8 +/- 0.4 x 10(-5) M, n = 9 (ISE); similar to phase 3 EC(50). Because NaHS has substantial vasoactive effects at physiological plasma concentrations, we propose that its soluble derivative, H(2)S, is a tonically active endogenous vasoregulator in trout.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003943     DOI: 10.1152/ajpregu.00419.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  39 in total

Review 1.  Modes of physiologic H2S signaling in the brain and peripheral tissues.

Authors:  Bindu D Paul; Solomon H Snyder
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

Review 2.  Hydrogen sulphide as a signalling molecule regulating physiopathological processes in gastrointestinal motility.

Authors:  M Jimenez; V Gil; M Martinez-Cutillas; N Mañé; D Gallego
Journal:  Br J Pharmacol       Date:  2017-07-27       Impact factor: 8.739

3.  Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.

Authors:  Yeshi Hu; Xin Chen; Ting-Ting Pan; Kay Li Neo; Shiau Wei Lee; Ester Sandar Win Khin; Philip K Moore; Jin-Song Bian
Journal:  Pflugers Arch       Date:  2007-08-01       Impact factor: 3.657

4.  Actions of a hydrogen sulfide donor (NaHS) on transient sodium, persistent sodium, and voltage-gated calcium currents in neurons of the subfornical organ.

Authors:  Markus Kuksis; Alastair V Ferguson
Journal:  J Neurophysiol       Date:  2015-07-15       Impact factor: 2.714

5.  Development of hydrogen sulfide-based therapeutics for cardiovascular disease.

Authors:  Benjamin L Predmore; David J Lefer
Journal:  J Cardiovasc Transl Res       Date:  2010-07-14       Impact factor: 4.132

6.  Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?

Authors:  M Y Ali; C Y Ping; Y-Yp Mok; L Ling; M Whiteman; M Bhatia; P K Moore
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

7.  Hydrogen sulfide modulates contractile function in rat jejunum.

Authors:  Michael S Kasparek; David R Linden; Gianrico Farrugia; Michael G Sarr
Journal:  J Surg Res       Date:  2011-04-22       Impact factor: 2.192

8.  H(2)S and HS(-) donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells.

Authors:  Karol Ondrias; Andrej Stasko; Sona Cacanyiova; Zdena Sulova; Olga Krizanova; Frantisek Kristek; Lubica Malekova; Vladimir Knezl; Albert Breier
Journal:  Pflugers Arch       Date:  2008-05-06       Impact factor: 3.657

Review 9.  Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide.

Authors:  Daniele Mancardi; Claudia Penna; Annalisa Merlino; Piero Del Soldato; David A Wink; Pasquale Pagliaro
Journal:  Biochim Biophys Acta       Date:  2009-03-13

Review 10.  Endogenous production of H2S in the gastrointestinal tract: still in search of a physiologic function.

Authors:  David R Linden; Michael D Levitt; Gianrico Farrugia; Joseph H Szurszewski
Journal:  Antioxid Redox Signal       Date:  2010-05-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.